Company Analysis
Sign in

Oaktree Acquisition Corp. III Life Sciences (OACC)

Nasdaq: OACC · Blank Checks · Los Angeles, CA · filing with the SEC since 2024
Full chart Alerts Compare
Grade5.5
◀ Past 5.3● Present 5.1▶ Future 6.1
8 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Who owns Oaktree Acquisition Corp. III Life Sciences

As filed with the SEC
Holders of 5% or more
6
Oaktree Acquisition Holdings III LS, LLC holds 22.3% of Class A ordinary shares, par value $0.0001, as its SCHEDULE 13G filed Feb 12, 2025 says.
Directors and officers
2
report now, of 10 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Oaktree Acquisition Holdings III LS, LLC
SCHEDULE 13G · filed Feb 12, 2025 · Class A ordinary shares, par value $0.0001
22.3%
AQR Capital Management, LLC
SCHEDULE 13G/A · filed May 14, 2025 · Class A ordinary share, $0.0001 par value
7.33%
Barclays PLC
SCHEDULE 13G · filed Aug 13, 2026 · COMMON-STOCK · 4.35% in Feb 11, 2026
6.99%
Goldman Sachs Group Inc.
SCHEDULE 13G · filed May 11, 2026 · Class A ordinary shares, par value $0.0001 per share · 4.1% in Aug 12, 2025
6.2%
Decagon Asset Management LLP
SCHEDULE 13G · filed Aug 14, 2026 · Class A ordinary shares, par value $0.0001 per share
5.52%
Fort Baker Capital Management LP
SCHEDULE 13G · filed May 15, 2026 · Class A ordinary shares, par value $0.0001 per share
5.1%
Healthcare of Ontario Pension Plan Trust Fund
SCHEDULE 13G/A · filed May 14, 2025 · Class A ordinary shares, $0.0001 par value · reported falling below 5%, from 8.6% in Feb 14, 2025
under 5%
Millennium Management LLC
SCHEDULE 13G/A · filed Jul 15, 2025 · Class A Ordinary Shares, par value $0.0001 per share · reported falling below 5%
under 5%
What OACC reports owning in othersstakes of 5% or more, and other ties
Oaktree Acquisition Corp. III Life Sciences reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 23, 2025 to Oct 23, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.
SI Assistanton OACC · research, not advice